We used the TCGA EC cohort to compare the 13 ECs with combined POLE mutation and TP53 mutation (POLEmut–p53abn) with tumours with either defect alone (single‐classifier POLEmut and single‐classifier p53abn EC). Here, POLE is linked to neoplasm.